TCM
TECH icon

Tamarack Capital Management’s Bio-Techne TECH Stock Holding History

Tamarack Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-323,116
Closed -$7.95M – 39
2015
Q2 		$7.95M Sell
323,116
-136,884
-30% -$3.42M 0.91% 27
2015
Q1 		$11.5M Buy
460,000
+300,000
+188% +$7.13M 1.52% 23
2014
Q4 		$3.7M Buy
+160,000
New +$3.66M 0.56% 33

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Tamarack Capital Management's TECH Position: Q3 2015 in Review

Tamarack Capital Management sold out of Bio-Techne (TECH) in Q3 2015, closing a stake of 323,116 shares — an estimated $7.95M sold.

Tamarack Capital Management first reported a position in TECH in Q4 2014 and held it in 3 quarters. The position peaked at $11.5M in Q1 2015. 250 funds tracked by Wall St. Rank hold TECH as of Q3 2015.

  • Tamarack Capital Management reported no remaining Bio-Techne position as of Q3 2015 after selling out during the quarter.
  • Tamarack Capital Management sold 323,116 Bio-Techne shares in Q3 2015, an estimated $7.95M.
  • Tamarack Capital Management first reported a position in Bio-Techne in Q4 2014 and held it in 3 quarters.
  • Tamarack Capital Management's Bio-Techne position peaked at $11.5M in Q1 2015.
  • 250 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2015.

Based on Tamarack Capital Management's 13F filing for Q3 2015, filed 10 Nov 2015.